BFM
AGL icon

Boothbay Fund Management’s Agilon Health AGL Stock Holding History

Boothbay Fund Management’s Portfolio AGL Stock Details AGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,230
Closed -$58.4K – 1372
2024
Q4 		$58.4K Buy
+1,230
New +$74.4K ﹤0.01% 1339
2024
Q3 		– Sell
-1,985
Closed -$325K – 1583
2024
Q2 		$325K Buy
+1,985
New +$283K 0.01% 1134
2023
Q3 		– Sell
-473
Closed -$205K – 1692
2023
Q2 		$205K Buy
+473
New +$266K ﹤0.01% 1482
2022
Q4 		– Sell
-496
Closed -$291K – 1966
2022
Q3 		$291K Buy
+496
New +$297K 0.01% 1557
2021
Q4 		– Sell
-2,838
Closed -$1.86M – 1825
2021
Q3 		$1.86M Buy
+2,838
New +$2.42M 0.05% 477

Other funds holding AGL

CDR
Clayton Dubilier & Rice New York $536M AUM 0.63% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Boothbay Fund Management's AGL Position: Q1 2025 in Review

Boothbay Fund Management sold out of Agilon Health (AGL) in Q1 2025, closing a stake of 1,230 shares — an estimated $58.4K sold.

Boothbay Fund Management first reported a position in AGL in Q3 2021 and held it in 5 quarters. The position peaked at $1.86M in Q3 2021. 197 funds tracked by Wall St. Rank hold AGL as of Q1 2025.

  • Boothbay Fund Management reported no remaining Agilon Health position as of Q1 2025 after selling out during the quarter.
  • Boothbay Fund Management sold 1,230 Agilon Health shares in Q1 2025, an estimated $58.4K.
  • Boothbay Fund Management first reported a position in Agilon Health in Q3 2021 and held it in 5 quarters.
  • Boothbay Fund Management's Agilon Health position peaked at $1.86M in Q3 2021.
  • 197 funds tracked by Wall St. Rank held Agilon Health as of Q1 2025.

Based on Boothbay Fund Management's 13F filing for Q1 2025, filed 15 May 2025.